ArticleDiscover oncology2026

Exploring the efficacy of XAV939 and LF3 in targeting β-catenin signalling in gallbladder cancer cell lines.

Akanksha Kashyap et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.